Enhanced recognition of human NK receptors after influenza virus infection

Journal of Immunology

Volumn 171, Issue 2, 2003, Pages 915-923

  Achdout, Hagit ^a   Arnon, Tal I ^a   Markel, Gal ^a   Gonen Gross, Tsufit ^a   Katz, Gil ^a   Lieberman, Niva ^a   Gazit, Roi ^a   Joseph, Aviva ^a   Kedar, Eli ^a   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; HN PROTEIN; IMMUNOGLOBULIN LIKE RECEPTOR 1; IMMUNOGLOBULIN LIKE RECEPTOR 2; IMMUNOGLOBULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; INFLUENZA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TARGET CELL;

EID: 0038783505     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.2.915     Document Type: Article

References (33)

1. Vilches, C., and P. Parham. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20:217.
2. Biassoni, R., C. Cantoni, D. Pende, S. Sivori, S. Parolini, M. Vitale, C. Bottino, and A. Moretta. 2001. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181:203.
3. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197.
4. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055.
5. Arnon, T. I., M. Lev, G. Katz, Y. Chemobrov, A. Porgador, and O. Mandelboim. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2680.
6. Lopez-Botet, M., and T. Bellon. 1999. Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Opin. Immunol. 11:301.
7. Natarajan, K., N. Dimasi, J. Wang, R. A. Mariuzza, and D. H. Margulies. 2002. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 20:853.
8. Moretta, A., R. Biassoni, C. Bottino, and L. Moretta. 2000. Surface receptors delivering opposite signals regulate the function of human NK cells. Semin. Immunol. 12:129.
9. Markel, G., N. Lieberman, G. Katz, T. I. Arnon, M. Lotem, O. Drize, R. S. Blumberg, E. Bar-Haim, R. Mader, L. Eisenbach, and O. Mandelboim. 2002. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J. Immunol. 168:2803.
10. Markel, G., D. Wolf, J. Hanna, R. Gazit, D. Goldman-Wohl, Y. Lavy, S. Yagel, and O. Mandelboim. 2002. Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J. Clin. Invest. 110:943.
11. Mandelboim, O., H. T. Reyburn, M. Vales-Gomez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp. Med. 184:913.
12. Fan, Q. R., E. O. Long, and D. C. Wiley. 2001. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat. Immun. 2:452.
13. Davis, D. M., I. Chiu, M. Fassett, G. B. Cohen, O. Mandelboim, and J. L. Strominger. 1999. The human natural killer cell immune synapse. Proc. Natl. Acad. Sci. USA 96:15062.
14. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective down-regulation of class 1 major histocompafibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661.
15. Melero, I., A. Salmeron, M. A. Balboa, J. Aramburu, and M. Lopez-Botet. 1994. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immunol. 152:1662.
16. Gelin, C., F. Aubrit, A. Phalipon, B. Raynal, S. Cole, M. Kaczorek, and A. Bernard. 1989. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J. 8:3253.
17. Ben-Yehuda, A., A. Joseph, E. Zeira, S. Even-Chen, I. Louria-Hayon, I. Babai, Z. Zakay-Rones, E. Greenbaum, Y. Barenholz, and E. Kedar. 2003. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOMEVAC) in young adults. J. Med. Virol. 69:560.
18. Sever, J. 1962. Application of microtechnique to viral serologic investigation. J. Immunol. 88:321.
19. Mandelboim, O., P. Malik, D. M. Davis, C. H. Jo, J. E. Boyson, and J. L. Strominger. 1999. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc. Natl. Acad. Sci. USA 96:5640.
20. Mandelboim, O., H. T. Reyburn, E. G. Sheu, M. Vales-Gomez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The binding site of NK receptors on HLA-C molecules. Immunity 6:341.
21. Carlin, L. M., K. Eleme, F. E. McCann, and D. M. Davis. 2001. Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J. Exp. Med. 194:1507.
22. Davis, D. M., O. Mandelboim, I. Luque, E. Baba, J. Boyson, and J. L. Strominger. 1999. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells. J. Exp. Med. 189:1265.
23. Vales-Gomez, M., H. T. Reyburn, M. Mandelboim, and J. L. Strominger. 1998. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 9:337.
24. Chapman, T. L., A. P. Heikeman, and P. J. Bjorkman. 1999. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11:603.
25. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273.
26. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809.
27. Fan, Q. R., E. O. Long, and D. C. Wiley. 2000. A disulfide-linked natural killer cell receptor dimer has higher affinity for HLA-C than wild-type monomer. Eur. J. Immunol. 30:2692.
28. Kambayashi, T., J. Michaelsson, L. Fahlen, B. J. Chambers, C. L. Sentman, K. Karre, and H. G. Ljunggren. 2001. Purified MHC class I molecules inhibit activated NK cells in a cell-free system in vitro. Eur. J. Immunol. 31:869.
29. Miller, D. M., C. M. Cebulla, and D. D. Sedmak. 2002. Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. Curr. Top. Microbiol. Immunol. 269:153.
30. De la Hoz, R. E., G. Stephens, and C. Sherlock. 2002. Diagnosis and treatment approaches of CMV infections in adult patients. J. Clin. Virol. 25(Suppl. 2):S1.
31. Furman, M. H., H. L. Ploegh, and D. J. Schust. 2000. Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface? Hum. Immunol. 61:1169.
32. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861.
33. Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, B. P. McSharry, S. Gadola, V. Cerundolo, L. K. Borysiewicz, A. J. McMichael, and G. W. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.